Health Care Supplies

MiniMed

MiniMed Group, Inc. Obtains Abbott CE Certification

MMED.US released FY2025 Semi-Annual Earnings on December 19, 2025 (BJT), with actual revenue of USD 1.304 B and EPS of USD 0

MiniMed released FY2026 Semi-Annual earnings on December 19, 2025 (EST), with actual revenue of USD 1.475 B and EPS of USD 0

MMED.US released FY2026 Q1 earnings on December 19, 2025 (BJT), with actual revenue of USD 737.5 M and EPS of USD 0

MMED.US released FY2025 Q1 earnings on December 19, 2025 (BJT) with actual revenue of USD 652 M and EPS of USD 0

MMED.US released FY2026 Q2 earnings on December 19, 2025 (BJT) with actual revenue of USD 737.5 M and EPS of USD 0

MMED.US released FY2025 Q2 earnings on December 19, 2025 (BJT) with actual revenue of USD 652M and EPS of USD 0

MiniMed released FY2025 Annual Earnings on October 28 (EST), actual revenue USD 2.715 B, actual EPS USD 0

MiniMed released FY2024 Annual Earnings on October 28 (EST), Actual Revenue: USD 2.469 B, Actual EPS: USD 0

MMED.US released FY2023 Annual Earnings on May 30, 2025 (BJT) with actual revenue of USD 2.245 B and EPS of USD 0

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

Agape ATP

Polaryx Therapeutics

Longeveron

IB ACQUISITION CORP. COM USD0.0001(S/R 28/03/26)

Decent

Acurx Pharmaceuticals

Macrogenics

T-Rex 2X Long FIGR Daily Target ETF

Nautics Robotics

Zenvia

MMED

SBIO

<p>MiniMed Closes IPO of 28 Million Shares at $20 Each</p>

marketscreener

Medtronic

iShares US Medical Devices

SPDR S&P Health Equip

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

ALPS Medical Breakthrough

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

MiniMed Closes IPO of 28 Million Shares at $20 Each

MINM

<p>MiniMed Group, Inc. (Nasdaq: MMED) has closed its initial public offering (IPO) of 28 million shares at $20.00 each, raising approximately $538 million after expenses. Medtronic plc retains about 90.03% ownership of MiniMed. The funds will be used for corporate purposes and to repay debt to Medtronic. The IPO was managed by Goldman Sachs, BofA Securities, Citigroup, and Morgan Stanley, among others. The offering was registered with the SEC and is aimed at enhancing MiniMed's position in the diabetes management market.</p>

StockTitan

Minim

MiniMed announces closing of Initial Public Offering | MMED Stock News

MiniMed(MMED.US)

Valuation analysis

Institutional View & Shareholder

Analyst Ratings

MiniMed Closes IPO of 28 Million Shares at $20 Each

MiniMed announces closing of Initial Public Offering | MMED Stock News